866-997-4948(US-Canada Toll Free)

Genethon SA - Product Pipeline Review - 2016

Published By :

Global Markets Direct

Published Date : Dec 2016

Category :

Pharmaceutical

No. of Pages : 42 Pages

Genethon SA - Product Pipeline Review - 2016

Summary

Global Markets Directs, Genethon SA - Product Pipeline Review - 2016, provides an overview of the Genethon SAs pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Genethon SA, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Genethon SA
- The report provides overview of Genethon SA including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Genethon SAs pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Genethon SAs out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Genethon SAs strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Genethon SA
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Genethon SAs pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Genethon SA Snapshot 6
Genethon SA Overview 6
Key Facts 6
Genethon SA - Research and Development Overview 7
Key Therapeutic Areas 7
Genethon SA - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Genethon SA - Pipeline Products Glance 14
Genethon SA - Clinical Stage Pipeline Products 14
Phase II Products/Combination Treatment Modalities 14
Genethon SA - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Genethon SA - Drug Profiles 17
Cell Therapy to Activate FANC-A for Fanconi Anemia - Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
CPK-850 - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
G-1XCGD - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
Gene Therapy for Duchenne Muscular Dystrophy - Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
Gene Therapy for Sickle Cell Disease - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
Gene Therapy to Activate Dysferlin for Dysferlinopathies - Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
Gene Therapy to Activate Dystrophin for Duchenne Muscular Dystrophy - Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
Gene Therapy to Activate Factor IX for Hemophilia B - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
Gene Therapy to Activate Gamma-Sarcoglycan for Gamma Sarcoglycanopathy - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
Gene Therapy to Activate IL2RG for SCID-X1 - Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
Gene Therapy to Activate SGCA for Alpha-Sarcoglycanopathy - Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
Gene Therapy to Activate SMN1 for Spinal Muscular Atrophy - Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
Gene Therapy to Activate UGT1A1 for Crigler-Najjar Syndrome - Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
Stem Cell Therapy to Activate Artemis for Radiosensitive Severe Combined Immunodeficiency - Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
Stem Cell Therapy to Activate WASP for Wiskott-Aldrich Syndrome - Drug Profile 33
Product Description 33
Mechanism Of Action 33
R&D Progress 33
Genethon SA - Pipeline Analysis 35
Genethon SA - Pipeline Products by Target 35
Genethon SA - Pipeline Products by Route of Administration 36
Genethon SA - Pipeline Products by Molecule Type 37
Genethon SA - Pipeline Products by Mechanism of Action 38
Genethon SA - Dormant Projects 39
Genethon SA - Locations And Subsidiaries 40
Head Office 40
Appendix 41
Methodology 41
Coverage 41
Secondary Research 41
Primary Research 41
Expert Panel Validation 41
Contact Us 41
Disclaimer 42

List of Tables
Genethon SA, Key Facts 6
Genethon SA - Pipeline by Indication, 2016 9
Genethon SA - Pipeline by Stage of Development, 2016 10
Genethon SA - Monotherapy Products in Pipeline, 2016 11
Genethon SA - Partnered Products in Pipeline, 2016 12
Genethon SA - Partnered Products/ Combination Treatment Modalities, 2016 13
Genethon SA - Phase II, 2016 14
Genethon SA - Preclinical, 2016 15
Genethon SA - Discovery, 2016 16
Genethon SA - Pipeline by Target, 2016 35
Genethon SA - Pipeline by Route of Administration, 2016 36
Genethon SA - Pipeline by Molecule Type, 2016 37
Genethon SA - Pipeline Products by Mechanism of Action, 2016 38
Genethon SA - Dormant Developmental Projects,2016 39

List of Figures
Genethon SA - Pipeline by Top 10 Indication, 2016 8
Genethon SA - Pipeline by Stage of Development, 2016 10
Genethon SA - Monotherapy Products in Pipeline, 2016 11
Genethon SA - Partnered Products in Pipeline, 2016 12
Genethon SA - Pipeline by Top 10 Target, 2016 35
Genethon SA - Pipeline by Route of Administration, 2016 36
Genethon SA - Pipeline by Molecule Type, 2016 37
Genethon SA - Pipeline Products by Top 10 Mechanism of Action, 2016 38

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *